BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Reynaert H, Thompson MG, Thomas T, Geerts A. Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension. Gut. 2002;50:571-581. [PMID: 11889082 DOI: 10.1136/gut.50.4.571] [Cited by in Crossref: 194] [Cited by in F6Publishing: 184] [Article Influence: 10.2] [Reference Citation Analysis]
Number Citing Articles
1 Zhou Q, Hennenberg M, Trebicka J, Jochem K, Leifeld L, Biecker E, Sauerbruch T, Heller J. Intrahepatic upregulation of RhoA and Rho-kinase signalling contributes to increased hepatic vascular resistance in rats with secondary biliary cirrhosis. Gut. 2006;55:1296-1305. [PMID: 16492715 DOI: 10.1136/gut.2005.081059] [Cited by in Crossref: 66] [Cited by in F6Publishing: 65] [Article Influence: 4.4] [Reference Citation Analysis]
2 金世柱, 孟祥伟, 韩明子. 门脉高压性胃病的研究进展. 世界华人消化杂志 2009; 17(1): 59-62 [DOI: 10.11569/wcjd.v17.i1.59] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
3 Kojima N, Hori M, Murata T, Morizane Y, Ozaki H. Different profiles of Ca2+ responses to endothelin-1 and PDGF in liver myofibroblasts during the process of cell differentiation. Br J Pharmacol 2007;151:816-27. [PMID: 17533428 DOI: 10.1038/sj.bjp.0707269] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
4 Adrian JE, Poelstra K, Scherphof GL, Meijer DK, van Loenen-Weemaes AM, Reker-Smit C, Morselt HW, Zwiers P, Kamps JA. Effects of a new bioactive lipid-based drug carrier on cultured hepatic stellate cells and liver fibrosis in bile duct-ligated rats. J Pharmacol Exp Ther 2007;321:536-43. [PMID: 17314198 DOI: 10.1124/jpet.106.117945] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
5 Wang Y, Li J, Wang X, Ye L, Zhou Y, Ho W. Induction of interferon-λ contributes to Toll-like receptor-3-activated hepatic stellate cell-mediated hepatitis C virus inhibition in hepatocytes. J Viral Hepat 2013;20:385-94. [PMID: 23647955 DOI: 10.1111/jvh.12040] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
6 Lubel JS, Angus PW. Modern management of portal hypertension. Intern Med J. 2005;35:45-49. [PMID: 15667468 DOI: 10.1111/j.1445-5994.2004.00739.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
7 Renga B, Francisci D, Schiaroli E, Carino A, Cipriani S, D'Amore C, Sidoni A, Sordo RD, Ferri I, Lucattelli M, Lunghi B, Baldelli F, Fiorucci S. The HIV matrix protein p17 promotes the activation of human hepatic stellate cells through interactions with CXCR2 and Syndecan-2. PLoS One 2014;9:e94798. [PMID: 24736615 DOI: 10.1371/journal.pone.0094798] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
8 Ezhilarasan D. Endothelin-1 in portal hypertension: The intricate role of hepatic stellate cells. Exp Biol Med (Maywood) 2020;245:1504-12. [PMID: 32791849 DOI: 10.1177/1535370220949148] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
9 Wu L, Lu I, Chung C, Wu H, Liu Y. Antiproliferative mechanisms of quercetin in rat activated hepatic stellate cells. Food Funct 2011;2:204. [DOI: 10.1039/c0fo00158a] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
10 Halangk J, Berg T, Neumann K, Sarrazin C, Hinrichsen H, Fitz C, Puhl G, Mueller T, Neuhaus P, Wiedenmann B, Witt H. Evaluation of angiotensinogen c.1-44G>A and p.M268T variants as risk factors for fibrosis progression in chronic hepatitis C and liver diseases of various etiologies. Genet Test Mol Biomarkers 2009;13:407-14. [PMID: 19473084 DOI: 10.1089/gtmb.2008.0135] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
11 Wang Y, Ye L, Wang X, Li J, Song L, Ho W. Retinoic acid inducible gene-I (RIG-I) signaling of hepatic stellate cells inhibits hepatitis C virus replication in hepatocytes. Innate Immun 2013;19:193-202. [PMID: 23060457 DOI: 10.1177/1753425912460414] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
12 Watson P. Chronic hepatitis in dogs: a review of current understanding of the aetiology, progression, and treatment. The Veterinary Journal 2004;167:228-41. [DOI: 10.1016/s1090-0233(03)00118-7] [Cited by in Crossref: 50] [Cited by in F6Publishing: 9] [Article Influence: 2.9] [Reference Citation Analysis]
13 Reynaert H, Urbain D, Geerts A. Regulation of sinusoidal perfusion in portal hypertension. Anat Rec (Hoboken). 2008;291:693-698. [PMID: 18484616 DOI: 10.1002/ar.20669] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
14 Kolodziejczyk AA, Federici S, Zmora N, Mohapatra G, Dori-bachash M, Hornstein S, Leshem A, Reuveni D, Zigmond E, Tobar A, Salame TM, Harmelin A, Shlomai A, Shapiro H, Amit I, Elinav E. Acute liver failure is regulated by MYC- and microbiome-dependent programs. Nat Med 2020;26:1899-911. [DOI: 10.1038/s41591-020-1102-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 15.0] [Reference Citation Analysis]
15 Chen Y, Sun W, Kang L, Wang Y, Zhang M, Zhang H, Hu P. Microfluidic co-culture of liver tumor spheroids with stellate cells for the investigation of drug resistance and intercellular interactions. Analyst 2019;144:4233-40. [DOI: 10.1039/c9an00612e] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 7.5] [Reference Citation Analysis]
16 Winau F, Quack C, Darmoise A, Kaufmann SH. Starring stellate cells in liver immunology. Curr Opin Immunol. 2008;20:68-74. [PMID: 18068343 DOI: 10.1016/j.coi.2007.10.006] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 3.9] [Reference Citation Analysis]
17 Geerts A. The simple truth is seldom true and never simple: dual role for p75(NTR) in transdifferentation and cell death of hepatic stellate cells. Hepatology. 2007;46:600-601. [PMID: 17661415 DOI: 10.1002/hep.21861] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
18 Ling L, Li G, Wang G, Meng D, Li Z, Zhang C. Carvedilol improves liver cirrhosis in rats by inhibiting hepatic stellate cell activation, proliferation, invasion and collagen synthesis. Mol Med Rep 2019;20:1605-12. [PMID: 31257490 DOI: 10.3892/mmr.2019.10401] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Shen H, Zhang M, Kaita K, Minuk GY, Rempel J, Gong Y. Expression of Fc fragment receptors of immunoglobulin G (Fc gammaRs) in rat hepatic stellate cells. Dig Dis Sci. 2005;50:181-187. [PMID: 15712658 DOI: 10.1007/s10620-005-1298-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
20 Møller S, Henriksen JH, Bendtsen F. Extrahepatic complications to cirrhosis and portal hypertension: Haemodynamic and homeostatic aspects. World J Gastroenterol 2014; 20(42): 15499-15517 [PMID: 25400435 DOI: 10.3748/wjg.v20.i42.15499] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 31] [Article Influence: 5.6] [Reference Citation Analysis]
21 Fallowfield JA, Hayden AL, Snowdon VK, Aucott RL, Stutchfield BM, Mole DJ, Pellicoro A, Gordon-Walker TT, Henke A, Schrader J. Relaxin modulates human and rat hepatic myofibroblast function and ameliorates portal hypertension in vivo. Hepatology. 2014;59:1492-1504. [PMID: 23873655 DOI: 10.1002/hep.26627] [Cited by in Crossref: 67] [Cited by in F6Publishing: 61] [Article Influence: 9.6] [Reference Citation Analysis]
22 Ghiassi-Nejad Z, Friedman SL. Advances in antifibrotic therapy. Expert Rev Gastroenterol Hepatol. 2008;2:803-816. [PMID: 19090740 DOI: 10.1586/17474124.2.6.803] [Cited by in Crossref: 64] [Cited by in F6Publishing: 60] [Article Influence: 5.3] [Reference Citation Analysis]
23 Fiorucci S, Antonelli E, Mencarelli A, Orlandi S, Renga B, Rizzo G, Distrutti E, Shah V, Morelli A. The third gas: H2S regulates perfusion pressure in both the isolated and perfused normal rat liver and in cirrhosis. Hepatology. 2005;42:539-548. [PMID: 16108046 DOI: 10.1002/hep.20817] [Cited by in Crossref: 424] [Cited by in F6Publishing: 383] [Article Influence: 26.5] [Reference Citation Analysis]
24 Ezhilarasan D. Hepatic stellate cells in the injured liver: Perspectives beyond hepatic fibrosis. J Cell Physiol 2021. [PMID: 34514599 DOI: 10.1002/jcp.30582] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Turner N, Nolasco L, Tao Z, Dong JF, Moake J. Human endothelial cells synthesize and release ADAMTS-13. J Thromb Haemost 2006;4:1396-404. [PMID: 16706987 DOI: 10.1111/j.1538-7836.2006.01959.x] [Cited by in Crossref: 119] [Cited by in F6Publishing: 100] [Article Influence: 8.5] [Reference Citation Analysis]
26 Kobayashi H, Li Z, Yamataka A, Lane GJ, Miyano T. Role of immunologic costimulatory factors in the pathogenesis of biliary atresia. J Pediatr Surg 2003;38:892-6. [PMID: 12778387 DOI: 10.1016/s0022-3468(03)00117-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
27 Najar M, Fayyad-Kazan H, Faour WH, El Taghdouini A, Raicevic G, Najimi M, Toungouz M, van Grunsven LA, Sokal E, Lagneaux L. Human hepatic stellate cells and inflammation: A regulated cytokine network balance. Cytokine 2017;90:130-4. [PMID: 27865205 DOI: 10.1016/j.cyto.2016.11.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
28 Adrian JE, Poelstra K, Kamps JA. Addressing liver fibrosis with liposomes targeted to hepatic stellate cells. J Liposome Res. 2007;17:205-218. [PMID: 18027241 DOI: 10.1080/08982100701528047] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
29 Zhang Y, Ikegami T, Honda A, Miyazaki T, Bouscarel B, Rojkind M, Hyodo I, Matsuzaki Y. Involvement of integrin-linked kinase in carbon tetrachloride-induced hepatic fibrosis in rats. Hepatology. 2006;44:612-622. [PMID: 16941698 DOI: 10.1002/hep.21315] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 2.8] [Reference Citation Analysis]
30 齐峰, 胡江峰, 唐丹, 刘保海, 朱樑. 应用二代测序技术筛选压力作用下肝星状细胞的差异表达基因. 世界华人消化杂志 2014; 22(23): 3380-3387 [DOI: 10.11569/wcjd.v22.i23.3380] [Reference Citation Analysis]
31 Verma A, Bennett J, Örme AM, Polycarpou E, Rooney B. Cocaine addicted to cytoskeletal change and a fibrosis high. Cytoskeleton (Hoboken) 2019;76:177-85. [PMID: 30623590 DOI: 10.1002/cm.21510] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
32 Li J, Kuruba R, Wilson A, Gao X, Zhang Y, Li S. Inhibition of endothelin-1-mediated contraction of hepatic stellate cells by FXR ligand. PLoS One. 2010;5:e13955. [PMID: 21085652 DOI: 10.1371/journal.pone.0013955] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
33 Benitez-Rajal J, Lorite MJ, Burt AD, Day CP, Thompson MG. Phospholipase D and extracellular signal-regulated kinase in hepatic stellate cells: effects of platelet-derived growth factor and extracellular nucleotides. Am J Physiol Gastrointest Liver Physiol 2006;291:G977-86. [PMID: 17030901 DOI: 10.1152/ajpgi.00041.2006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
34 Liu Z, van Grunsven LA, Van Rossen E, Schroyen B, Timmermans JP, Geerts A, Reynaert H. Blebbistatin inhibits contraction and accelerates migration in mouse hepatic stellate cells. Br J Pharmacol. 2010;159:304-315. [PMID: 20039876 DOI: 10.1111/j.1476-5381.2009.00477.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 4.4] [Reference Citation Analysis]
35 Song Z, Gupta K, Ng IC, Xing J, Yang YA, Yu H. Mechanosensing in liver regeneration. Seminars in Cell & Developmental Biology 2017;71:153-67. [DOI: 10.1016/j.semcdb.2017.07.041] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
36 Yang W, Benjamin IS, Moore K, Portmann B, Alexander B. The action of nitric oxide on hepatic haemodynamics during secondary biliary cirrhosis in the rat. Eur J Pharmacol. 2003;461:41-48. [PMID: 12568914 DOI: 10.1016/s0014-2999(03)01301-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
37 Oben JA, Roskams T, Yang S, Lin H, Sinelli N, Torbenson M, Smedh U, Moran TH, Li Z, Huang J, Thomas SA, Diehl AM. Hepatic fibrogenesis requires sympathetic neurotransmitters. Gut 2004;53:438-45. [PMID: 14960531 DOI: 10.1136/gut.2003.026658] [Cited by in Crossref: 115] [Cited by in F6Publishing: 113] [Article Influence: 6.8] [Reference Citation Analysis]
38 Rockey DC. Vascular mediators in the injured liver. Hepatology. 2003;37:4-12. [PMID: 12500181 DOI: 10.1053/jhep.2003.50044] [Cited by in Crossref: 124] [Cited by in F6Publishing: 105] [Article Influence: 6.9] [Reference Citation Analysis]
39 Knolle PA. The Liver and the Immune System. Zakim and Boyer's Hepatology. Elsevier; 2006. pp. 149-63. [DOI: 10.1016/b978-1-4160-3258-8.50014-0] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
40 Sancho-bru P, Bataller R, Colmenero J, Gasull X, Moreno M, Arroyo V, Brenner DA, Ginès P. Norepinephrine induces calcium spikes and proinflammatory actions in human hepatic stellate cells. American Journal of Physiology-Gastrointestinal and Liver Physiology 2006;291:G877-84. [DOI: 10.1152/ajpgi.00537.2005] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 2.8] [Reference Citation Analysis]
41 Turco L, Garcia-Tsao G. Portal Hypertension: Pathogenesis and Diagnosis. Clin Liver Dis. 2019;23:573-587. [PMID: 31563212 DOI: 10.1016/j.cld.2019.07.007] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 17.0] [Reference Citation Analysis]
42 Liang YJ, Luo J, Yuan Q, Zheng D, Liu YP, Shi L, Zhou Y, Chen AL, Ren YY, Sun KY. New insight into the antifibrotic effects of praziquantel on mice in infection with Schistosoma japonicum. PLoS One. 2011;6:e20247. [PMID: 21629648 DOI: 10.1371/journal.pone.0020247] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 4.5] [Reference Citation Analysis]
43 Königshofer P, Brusilovskaya K, Petrenko O, Hofer BS, Schwabl P, Trauner M, Reiberger T. Nuclear Receptors in Liver Fibrosis. Biochim Biophys Acta Mol Basis Dis 2021;:166235. [PMID: 34339839 DOI: 10.1016/j.bbadis.2021.166235] [Reference Citation Analysis]
44 Nagata T, Kudo H, Nishino T, Doi Y, Itoh H, Fujimoto S. Increased immunoreactivities against endothelin-converting enzyme-1 and monocyte chemotactic protein-1 in hepatic stellate cells of rat fibrous liver induced by thioacetamide. Med Mol Morphol 2005;38:161-72. [PMID: 16170464 DOI: 10.1007/s00795-005-0292-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
45 Horst AK, Neumann K, Diehl L, Tiegs G. Modulation of liver tolerance by conventional and nonconventional antigen-presenting cells and regulatory immune cells. Cell Mol Immunol. 2016;13:277-292. [PMID: 27041638 DOI: 10.1038/cmi.2015.112] [Cited by in Crossref: 115] [Cited by in F6Publishing: 116] [Article Influence: 23.0] [Reference Citation Analysis]
46 Gioli-Pereira L, Nascimento EA, Santos EL, Bracht A, Juliano MA, Pesquero JB, Borges DR, Kouyoumdjian M. Fate of bradykinin on the rat liver when administered by the venous or arterial route. J Gastroenterol Hepatol. 2005;20:463-473. [PMID: 15740493 DOI: 10.1111/j.1440-1746.2005.03580.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
47 Gressner OA, Gao C. Monitoring fibrogenic progression in the liver. Clin Chim Acta. 2014;433:111-122. [PMID: 24607331 DOI: 10.1016/j.cca.2014.02.021] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
48 Rondonotti E, Villa F, Signorelli C, de Franchis R. Portal Hypertensive Enteropathy. Gastrointestinal Endoscopy Clinics of North America 2006;16:277-86. [DOI: 10.1016/j.giec.2006.01.019] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
49 Gao ZL, Gu XH, Cheng FT, Jiang FH. Effect of Sea buckthorn on liver fibrosis: A clinical study. World J Gastroenterol 2003; 9(7): 1615-1617 [PMID: 12854177 DOI: 10.3748/wjg.v9.i7.1615] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
50 Eipel C, Abshagen K, Vollmar B. Regulation of hepatic blood flow: The hepatic arterial buffer response revisited. World J Gastroenterol 2010; 16(48): 6046-6057 [PMID: 21182219 DOI: 10.3748/wjg.v16.i48.6046] [Cited by in CrossRef: 251] [Cited by in F6Publishing: 192] [Article Influence: 22.8] [Reference Citation Analysis]
51 Svegliati-Baroni G, Inagaki Y, Rincon-Sanchez AR, Else C, Saccomanno S, Benedetti A, Ramirez F, Rojkind M. Early response of alpha2(I) collagen to acetaldehyde in human hepatic stellate cells is TGF-beta independent. Hepatology. 2005;42:343-352. [PMID: 16025520 DOI: 10.1002/hep.20798] [Cited by in Crossref: 56] [Cited by in F6Publishing: 61] [Article Influence: 3.5] [Reference Citation Analysis]
52 Maschmeyer P, Flach M, Winau F. Seven steps to stellate cells. J Vis Exp 2011:2710. [PMID: 21610670 DOI: 10.3791/2710] [Cited by in Crossref: 26] [Cited by in F6Publishing: 36] [Article Influence: 2.6] [Reference Citation Analysis]
53 Ng WL, Chua CK, Shen Y. Print Me An Organ! Why We Are Not There Yet. Progress in Polymer Science 2019;97:101145. [DOI: 10.1016/j.progpolymsci.2019.101145] [Cited by in Crossref: 79] [Cited by in F6Publishing: 36] [Article Influence: 39.5] [Reference Citation Analysis]
54 Bataller R, Sancho-Bru P, Ginès P, Lora JM, Al-Garawi A, Solé M, Colmenero J, Nicolás JM, Jiménez W, Weich N. Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II. Gastroenterology. 2003;125:117-125. [PMID: 12851877 DOI: 10.1016/s0016-5085(03)00695-4] [Cited by in Crossref: 235] [Cited by in F6Publishing: 106] [Article Influence: 13.1] [Reference Citation Analysis]
55 Sacerdoti D, Pesce P, Di Pascoli M, Brocco S, Cecchetto L, Bolognesi M. Arachidonic acid metabolites and endothelial dysfunction of portal hypertension. Prostaglandins Other Lipid Mediat. 2015;120:80-90. [PMID: 26072731 DOI: 10.1016/j.prostaglandins.2015.05.008] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
56 Sarem M, Znaidak R, Macias M, Rey R. [Hepatic stellate cells: it's role in normal and pathological conditions]. Gastroenterol Hepatol. 2006;29:93-101. [PMID: 16448612 DOI: 10.1157/13083906] [Cited by in Crossref: 20] [Cited by in F6Publishing: 26] [Article Influence: 1.3] [Reference Citation Analysis]
57 Sera T, Sumii T, Fujita R, Kudo S. Effect of shear stress on the migration of hepatic stellate cells. In Vitro Cell Dev Biol -Animal 2018;54:11-22. [DOI: 10.1007/s11626-017-0202-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
58 Qin L, Han YP. Epigenetic repression of matrix metalloproteinases in myofibroblastic hepatic stellate cells through histone deacetylases 4: implication in tissue fibrosis. Am J Pathol. 2010;177:1915-1928. [PMID: 20847282 DOI: 10.2353/ajpath.2010.100011] [Cited by in Crossref: 65] [Cited by in F6Publishing: 69] [Article Influence: 5.9] [Reference Citation Analysis]
59 Majumder S, Tamilarasan KP, Kolluru GK, Muley A, Nair CM, Omanakuttan A, Murty KV, Chatterjee S. Activated pericyte attenuates endothelial functions: nitric oxide-cGMP rescues activated pericyte-associated endothelial dysfunctions. Biochem Cell Biol 2007;85:709-20. [PMID: 18059529 DOI: 10.1139/o07-140] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
60 Uyama N, Zhao L, Van Rossen E, Hirako Y, Reynaert H, Adams DH, Xue Z, Li Z, Robson R, Pekny M, Geerts A. Hepatic stellate cells express synemin, a protein bridging intermediate filaments to focal adhesions. Gut 2006;55:1276-89. [PMID: 16484507 DOI: 10.1136/gut.2005.078865] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 3.7] [Reference Citation Analysis]
61 Furuya S, Furuya K. Subepithelial fibroblasts in intestinal villi: roles in intercellular communication. Int Rev Cytol 2007;264:165-223. [PMID: 17964923 DOI: 10.1016/S0074-7696(07)64004-2] [Cited by in Crossref: 34] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
62 Dercle L, Billey C, Cognet T, Cassol E, Sinigaglia M, Pascal P, Berry I, Otal P, Bureau C, Lairez O. Spleno-hepatic index to predict portal hypertension by equilibrium radionuclide ventriculography. Nucl Med Commun 2018;39:1138-42. [PMID: 30371604 DOI: 10.1097/MNM.0000000000000927] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
63 Thomsen KL, De Chiara F, Rombouts K, Vilstrup H, Andreola F, Mookerjee RP, Jalan R. Ammonia: A novel target for the treatment of non-alcoholic steatohepatitis. Med Hypotheses 2018;113:91-7. [PMID: 29523305 DOI: 10.1016/j.mehy.2018.02.010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
64 Campos-Rodríguez R, Jarillo-Luna RA, Larsen BA, Rivera-Aguilar V, Ventura-Juárez J. Invasive amebiasis: a microcirculatory disorder? Med Hypotheses 2009;73:687-97. [PMID: 19540678 DOI: 10.1016/j.mehy.2009.05.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
65 Bexfield N. Canine Idiopathic Chronic Hepatitis. Vet Clin North Am Small Anim Pract 2017;47:645-63. [PMID: 28063746 DOI: 10.1016/j.cvsm.2016.11.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
66 Chen P, Li J, Huo Y, Lu J, Wan L, Li B, Gan R, Guo C. Orphan nuclear receptor NR4A2 inhibits hepatic stellate cell proliferation through MAPK pathway in liver fibrosis. PeerJ 2015;3:e1518. [PMID: 26713258 DOI: 10.7717/peerj.1518] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
67 Anthony B, Mathieson W, de Castro-Borges W, Allen J. Schistosoma mansoni: egg-induced downregulation of hepatic stellate cell activation and fibrogenesis. Exp Parasitol 2010;124:409-20. [PMID: 20045695 DOI: 10.1016/j.exppara.2009.12.009] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 3.4] [Reference Citation Analysis]
68 Irwin RD, Boorman GA, Cunningham ML, Heinloth AN, Malarkey DE, Paules RS. Application of Toxicogenomics to Toxicology: Basic Concepts in the Analysis of Microarray Data. Toxicol Pathol 2004;32:72-83. [DOI: 10.1080/01926230490424752] [Cited by in Crossref: 54] [Cited by in F6Publishing: 37] [Article Influence: 10.8] [Reference Citation Analysis]
69 Li F, Wang JY. Targeted delivery of drugs for liver fibrosis. Expert Opin Drug Deliv. 2009;6:531-541. [PMID: 19413460 DOI: 10.1517/17425240902936834] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
70 Bertolani C, Marra F. The role of adipokines in liver fibrosis. Pathophysiology. 2008;15:91-101. [PMID: 18602801 DOI: 10.1016/j.pathophys.2008.05.001] [Cited by in Crossref: 73] [Cited by in F6Publishing: 74] [Article Influence: 5.6] [Reference Citation Analysis]
71 Derbocio AM, Kelmer-bracht AM, Bracht L, Bracht A, Ishii-iwamoto EL. The hemodynamic effects of zymosan in the perfused rat liver. Vascular Pharmacology 2005;43:75-85. [DOI: 10.1016/j.vph.2005.05.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
72 Chen L, Guo YZ, Li AD, Ma JJ, Hao HY, Zhang D, Wang Y, Ji CG, Qi W, Wang J, Jiang HQ. Knockdown of Astrocyte Elevated Gene-1 Inhibits Activation of Hepatic Stellate Cells. Dig Dis Sci 2016;61:1961-71. [PMID: 26879903 DOI: 10.1007/s10620-016-4075-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
73 Ahn SY, Maeng YS, Kim YR, Choe YH, Hwang HS, Hyun YM. In vivo monitoring of dynamic interaction between neutrophil and human umbilical cord blood-derived mesenchymal stem cell in mouse liver during sepsis. Stem Cell Res Ther 2020;11:44. [PMID: 32014040 DOI: 10.1186/s13287-020-1559-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
74 Gressner OA, Weiskirchen R, Gressner AM. Evolving concepts of liver fibrogenesis provide new diagnostic and therapeutic options. Comp Hepatol. 2007;6:7. [PMID: 17663771 DOI: 10.1186/1476-5926-6-7] [Cited by in Crossref: 84] [Cited by in F6Publishing: 92] [Article Influence: 6.0] [Reference Citation Analysis]
75 El-tanbouly DM, Wadie W, Sayed RH. Modulation of TGF-β/Smad and ERK signaling pathways mediates the anti-fibrotic effect of mirtazapine in mice. Toxicology and Applied Pharmacology 2017;329:224-30. [DOI: 10.1016/j.taap.2017.06.012] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
76 Lee Y, Friedman SL. Fibrosis in the Liver. Development, Differentiation and Disease of the Para-Alimentary Tract. Elsevier; 2010. pp. 151-200. [DOI: 10.1016/b978-0-12-385233-5.00006-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
77 Pesce A, Scilletta R, Branca A, Nigro L, Montineri A, Larocca L, Fatuzzo F, Castaing M, Puleo S. Does transient elastography (FibroScan®) have a role in decision making in hepatocellular carcinoma? HPB (Oxford) 2012;14:403-8. [PMID: 22568417 DOI: 10.1111/j.1477-2574.2012.00465.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
78 Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 2008;88:125-72. [PMID: 18195085 DOI: 10.1152/physrev.00013.2007] [Cited by in Crossref: 1682] [Cited by in F6Publishing: 1621] [Article Influence: 129.4] [Reference Citation Analysis]
79 Rosa-toledo O, Almeida-chuffa LG, Martinez M, Felipe-pinheiro PF, Padovani CR, Martinez FE. Maternal separation on the ethanol-preferring adult rat liver structure. Annals of Hepatology 2015;14:910-8. [DOI: 10.5604/16652681.1171783] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
80 Reggio S, Pellegrinelli V, Clément K, Tordjman J. Fibrosis as a Cause or a Consequence of White Adipose Tissue Inflammation in Obesity. Curr Obes Rep 2013;2:1-9. [DOI: 10.1007/s13679-012-0037-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
81 Kamdem SD, Moyou-Somo R, Brombacher F, Nono JK. Host Regulators of Liver Fibrosis During Human Schistosomiasis. Front Immunol 2018;9:2781. [PMID: 30546364 DOI: 10.3389/fimmu.2018.02781] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 11.3] [Reference Citation Analysis]
82 Hutchison N, Fligny C, Duffield JS. Resident mesenchymal cells and fibrosis. Biochim Biophys Acta 2013;1832:962-71. [PMID: 23220259 DOI: 10.1016/j.bbadis.2012.11.015] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
83 Marí M. IGFBP-3: So Much More Than an IGF1/2 Binding Protein. Cell Mol Gastroenterol Hepatol 2020;10:643-4. [PMID: 32634379 DOI: 10.1016/j.jcmgh.2020.06.006] [Reference Citation Analysis]
84 Kabra H, Walimbe T, Stuart K, Indey C, Jalgaonkar S, Ikwa E, Skurnac T, Chen J, Woolley A, Snead NM, Bachtell N, Leeming DJ, Karsdal M, Prestwich G, Panitch A, Paderi J. Localized inhibition of platelets and platelet derived growth factor by a matrix targeted glycan mimetic significantly attenuates liver fibrosis. Biomaterials 2021;269:120538. [PMID: 33246740 DOI: 10.1016/j.biomaterials.2020.120538] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
85 马骁, 刘冰熔. 门静脉高压药物治疗的新进展. 世界华人消化杂志 2008; 16(33): 3775-3781 [DOI: 10.11569/wcjd.v16.i33.3775] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
86 Duong HT, Dong Z, Su L, Boyer C, George J, Davis TP, Wang J. The use of nanoparticles to deliver nitric oxide to hepatic stellate cells for treating liver fibrosis and portal hypertension. Small. 2015;11:2291-2304. [PMID: 25641921 DOI: 10.1002/smll.201402870] [Cited by in Crossref: 58] [Cited by in F6Publishing: 58] [Article Influence: 9.7] [Reference Citation Analysis]
87 Reiter FP, Ye L, Ofner A, Schiergens TS, Ziesch A, Brandl L, Ben Khaled N, Hohenester S, Wimmer R, Artmann R, He Y, Lee SML, Mayr D, Zhang C, Gerbes AL, Mayerle J, Denk G, De Toni EN. p70 Ribosomal Protein S6 Kinase Is a Checkpoint of Human Hepatic Stellate Cell Activation and Liver Fibrosis in Mice. Cell Mol Gastroenterol Hepatol 2021;13:95-112. [PMID: 34537439 DOI: 10.1016/j.jcmgh.2021.09.001] [Reference Citation Analysis]
88 Wu Y, Li Z, Wang S, Xiu A, Zhang C. Carvedilol Inhibits Angiotensin II-Induced Proliferation and Contraction in Hepatic Stellate Cells through the RhoA/Rho-Kinase Pathway. Biomed Res Int 2019;2019:7932046. [PMID: 31828132 DOI: 10.1155/2019/7932046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
89 Bansal MB, Friedman SL. Hepatic Fibrogenesis. In: Dooley JS, Lok ASF, Burroughs AK, Heathcote EJ, editors. Sherlock's Diseases of the Liver and Biliary System. Oxford: Wiley-Blackwell; 2011. pp. 94-102. [DOI: 10.1002/9781444341294.ch6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
90 Oben JA, Diehl AM. Sympathetic nervous system regulation of liver repair. Anat Rec A Discov Mol Cell Evol Biol 2004;280:874-83. [PMID: 15382023 DOI: 10.1002/ar.a.20081] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 3.3] [Reference Citation Analysis]
91 Shao X, Uojima H, Setsu T, Okubo T, Atsukawa M, Furuichi Y, Arase Y, Hidaka H, Tanaka Y, Nakazawa T, Kako M, Kagawa T, Iwakiri K, Terai S, Koizumi W. Usefulness of autotaxin for the complications of liver cirrhosis. World J Gastroenterol 2020; 26(1): 97-108 [PMID: 31933517 DOI: 10.3748/wjg.v26.i1.97] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
92 Puche JE, Saiman Y, Friedman SL. Hepatic stellate cells and liver fibrosis. Compr Physiol. 2013;3:1473-1492. [PMID: 24265236 DOI: 10.1002/cphy.c120035] [Cited by in Crossref: 347] [Cited by in F6Publishing: 341] [Article Influence: 49.6] [Reference Citation Analysis]
93 Wang Y, Li J, Wang X, Sang M, Ho W. Hepatic stellate cells, liver innate immunity, and hepatitis C virus. J Gastroenterol Hepatol 2013;28 Suppl 1:112-5. [PMID: 23855305 DOI: 10.1111/jgh.12023] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
94 翟云, 蔡照华, 王利军, 丁惠国. 气体信号分子H2S在肝硬化门脉高压形成中的作用. 世界华人消化杂志 2009; 17(26): 2651-2653 [DOI: 10.11569/wcjd.v17.i26.2651] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
95 Palaniyappan N, Cox E, Bradley C, Scott R, Austin A, O'Neill R, Ramjas G, Travis S, White H, Singh R, Thurley P, Guha IN, Francis S, Aithal GP. Non-invasive assessment of portal hypertension using quantitative magnetic resonance imaging. J Hepatol. 2016;65:1131-1139. [PMID: 27475617 DOI: 10.1016/j.jhep.2016.07.021] [Cited by in Crossref: 55] [Cited by in F6Publishing: 43] [Article Influence: 11.0] [Reference Citation Analysis]
96 Teranishi Y, Matsubara T, Krausz KW, Le TT, Gonzalez FJ, Yoshizato K, Ikeda K, Kawada N. Involvement of hepatic stellate cell cytoglobin in acute hepatocyte damage through the regulation of CYP2E1-mediated xenobiotic metabolism. Lab Invest 2015;95:515-24. [PMID: 25686096 DOI: 10.1038/labinvest.2015.29] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
97 Pedersen JF, Larsen VA, Bytzer P, Madsen LG, Hamberg O. Hepatic transit time of ultrasound contrast in biopsy characterized liver disease. Acta Radiol 2005;46:557-60. [DOI: 10.1080/02841850510021689] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
98 Lee DH, Kong ID, Lee JW, Park KS. Changes in inward rectifier K+ channels in hepatic stellate cells during primary culture. Yonsei Med J 2008;49:459-71. [PMID: 18581597 DOI: 10.3349/ymj.2008.49.3.459] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
99 Moal F, Veal N, Vuillemin E, Barrière E, Wang J, Fizanne L, Oberti F, Douay O, Gallois Y, Bonnefont-Rousselot D, Rousselet MC, Calès P. Hemodynamic and antifibrotic effects of a selective liver nitric oxide donor V-PYRRO/NO in bile duct ligated rats. World J Gastroenterol 2006; 12(41): 6639-6645 [PMID: 17075977 DOI: 10.3748/wjg.v12.i41.6639] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
100 Nagy P, Thorgeirsson SS, Grisham JW. Organizational Principles of the Liver. In: Arias IM, Alter HJ, Boyer JL, Cohen DE, Shafritz DA, Thorgeirsson SS, Wolkoff AW, editors. The Liver. Wiley; 2020. pp. 1-13. [DOI: 10.1002/9781119436812.ch1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
101 Gock M, Eipel C, Linnebacher M, Klar E, Vollmar B. Impact of portal branch ligation on tissue regeneration, microcirculatory response and microarchitecture in portal blood-deprived and undeprived liver tissue. Microvasc Res. 2011;81:274-280. [PMID: 21397614 DOI: 10.1016/j.mvr.2011.03.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
102 Qi F, Hu JF, Liu BH, Wu CQ, Yu HY, Yao DK, Zhu L. MiR-9a-5p regulates proliferation and migration of hepatic stellate cells under pressure through inhibition of Sirt1. World J Gastroenterol 2015; 21(34): 9900-9915 [PMID: 26379395 DOI: 10.3748/wjg.v21.i34.9900] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
103 Ayabe S, Murata T, Maruyama T, Hori M, Ozaki H. Prostaglandin E2 induces contraction of liver myofibroblasts by activating EP3 and FP prostanoid receptors. Br J Pharmacol 2009;156:835-45. [PMID: 19239477 DOI: 10.1111/j.1476-5381.2008.00051.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
104 Soon RK, Yee HF. Stellate cell contraction: role, regulation, and potential therapeutic target. Clin Liver Dis. 2008;12:791-803, viii. [PMID: 18984467 DOI: 10.1016/j.cld.2008.07.004] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 3.3] [Reference Citation Analysis]
105 Miyata E, Masuya M, Yoshida S, Nakamura S, Kato K, Sugimoto Y, Shibasaki T, Yamamura K, Ohishi K, Nishii K, Ishikawa F, Shiku H, Katayama N. Hematopoietic origin of hepatic stellate cells in the adult liver. Blood 2008;111:2427-35. [DOI: 10.1182/blood-2007-07-101261] [Cited by in Crossref: 64] [Cited by in F6Publishing: 63] [Article Influence: 4.9] [Reference Citation Analysis]
106 Ding N, Yu RT, Subramaniam N, Sherman MH, Wilson C, Rao R, Leblanc M, Coulter S, He M, Scott C, Lau SL, Atkins AR, Barish GD, Gunton JE, Liddle C, Downes M, Evans RM. A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response. Cell. 2013;153:601-613. [PMID: 23622244 DOI: 10.1016/j.cell.2013.03.028] [Cited by in Crossref: 386] [Cited by in F6Publishing: 385] [Article Influence: 48.3] [Reference Citation Analysis]
107 Liu Z, Rossen EV, Timmermans J, Geerts A, van Grunsven LA, Reynaert H. Distinct roles for non-muscle myosin II isoforms in mouse hepatic stellate cells. Journal of Hepatology 2011;54:132-41. [DOI: 10.1016/j.jhep.2010.06.020] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
108 Xu H, Zhou Y, Lu C, Ping J, Xu LM. Salvianolic acid B lowers portal pressure in cirrhotic rats and attenuates contraction of rat hepatic stellate cells by inhibiting RhoA signaling pathway. Lab Invest. 2012;92:1738-1748. [PMID: 22986787 DOI: 10.1038/labinvest.2012.113] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
109 Wang X, Zhao W, Wang J, Shi K, Qin X, Kong Q, Wang G, Mu L, Li H, Sun B. Bone marrow stromal cells inhibit the activation of liver cirrhotic fat-storing cells via adrenomedullin secretion. Dig Dis Sci. 2015;60:1325-1334. [PMID: 25445161 DOI: 10.1007/s10620-014-3423-9] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
110 Debernardi-Venon W, Martini S, Biasi F, Vizio B, Termine A, Poli G, Brunello F, Alessandria C, Bonardi R, Saracco G, Rizzetto M, Marzano A. AT1 receptor antagonist Candesartan in selected cirrhotic patients: effect on portal pressure and liver fibrosis markers. J Hepatol 2007;46:1026-33. [PMID: 17336417 DOI: 10.1016/j.jhep.2007.01.017] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 3.8] [Reference Citation Analysis]
111 Omar R, Yang J, Liu H, Davies NM, Gong Y. Hepatic Stellate Cells in Liver Fibrosis and siRNA-Based Therapy. Rev Physiol Biochem Pharmacol 2016;172:1-37. [PMID: 27534415 DOI: 10.1007/112_2016_6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
112 Ma R, Chen J, Liang Y, Lin S, Zhu L, Liang X, Cai X. Sorafenib: A potential therapeutic drug for hepatic fibrosis and its outcomes. Biomedicine & Pharmacotherapy 2017;88:459-68. [DOI: 10.1016/j.biopha.2017.01.107] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 7.0] [Reference Citation Analysis]
113 Xu D, Wu Y, Liao ZX, Wang H. Protective effect of verapamil on multiple hepatotoxic factors-induced liver fibrosis in rats. Pharmacol Res. 2007;55:280-286. [PMID: 17223571 DOI: 10.1016/j.phrs.2006.12.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
114 Mounajjed T, Graham RP, Sanderson SO, Smyrk TC. Clinical associations of hepatic stellate cell (HSC) hyperplasia. Virchows Arch 2014;465:57-65. [DOI: 10.1007/s00428-014-1582-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
115 胡美迪, 郭贵海. 门静脉高压性肠病的研究现状. 世界华人消化杂志 2009; 17(20): 2054-2057 [DOI: 10.11569/wcjd.v17.i20.2054] [Reference Citation Analysis]
116 Guo CJ, Pan Q, Xiong H, Qiao YQ, Bian ZL, Zhong W, Sheng L, Li H, Shen L, Hua J, Ma X. Therapeutic potential of microRNA: a new target to treat intrahepatic portal hypertension? Biomed Res Int 2014;2014:797898. [PMID: 24812632 DOI: 10.1155/2014/797898] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
117 Abdel-Kawy HS. Effect of carvedilol versus propranolol on acute and chronic liver toxicity in rats. Drug Chem Toxicol 2021;44:101-11. [PMID: 30810389 DOI: 10.1080/01480545.2019.1576718] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
118 Xiao YH, Liu DW, Li Q. Effects of drug serum of anti-fibrosis I herbal compound on calcium in hepatic stellate cell and its molecular mechanism. World J Gastroenterol 2005; 11(10): 1515-1520 [PMID: 15770729 DOI: 10.3748/wjg.v11.i10.1515] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
119 Liang J, Deng X, Lin ZX, Zhao LC, Zhang XL. Attenuation of portal hypertension by natural taurine in rats with liver cirrhosis. World J Gastroenterol 2009; 15(36): 4529-4537 [PMID: 19777611 DOI: 10.3748/wjg.15.4529] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
120 You H, Harvie M, Du X, Rivera V, Zhang P, McManus DP. Protective Immune Responses Generated in a Murine Model Following Immunization with Recombinant Schistosoma japonicum Insulin Receptor. Int J Mol Sci 2018;19:E3088. [PMID: 30304851 DOI: 10.3390/ijms19103088] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
121 Gressner OA, Rizk MS, Kovalenko E, Weiskirchen R, Gressner AM. Changing the pathogenetic roadmap of liver fibrosis? Where did it start; where will it go? J Gastroenterol Hepatol. 2008;23:1024-1035. [PMID: 18505415 DOI: 10.1111/j.1440-1746.2008.05345.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 3.8] [Reference Citation Analysis]
122 de Oliveira da Silva B, Ramos LF, Moraes KCM. Molecular interplays in hepatic stellate cells: apoptosis, senescence, and phenotype reversion as cellular connections that modulate liver fibrosis. Cell Biol Int 2017;41:946-59. [PMID: 28498509 DOI: 10.1002/cbin.10790] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
123 Khimji AK, Rockey DC. Endothelin and hepatic wound healing. Pharmacol Res. 2011;63:512-518. [PMID: 21421048 DOI: 10.1016/j.phrs.2011.03.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
124 Geerts A, Pekny M. Hepatic stellate cells and astrocytes: similarities and differences. In: Häussinger D, Kircheis G, Schliess F, editors. Hepatic Encephalopathy and Nitrogen Metabolism. Dordrecht: Springer Netherlands; 2006. pp. 87-111. [DOI: 10.1007/1-4020-4456-9_6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
125 Seifalian AM, Mallick IH, Hajinasrollah E, Sogbodjor AL, Gustafsson BI, Delbro DS, Winslet MC. The in-vivo effect of pyrrolidine dithiocarbamate on hepatic parenchymal microcirculation and oxygenation of the rat liver. Eur J Gastroenterol Hepatol 2009;21:1184-90. [PMID: 19474746 DOI: 10.1097/MEG.0b013e32831d28cc] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
126 El-Husseini R, Kaplan MM. Reversal of portal hypertension in a patient with primary biliary cirrhosis: disappearance of esophageal varices and thrombocytopenia. Am J Gastroenterol 2004;99:1859-60. [PMID: 15330929 DOI: 10.1111/j.1572-0241.2004.30408.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
127 Alqahtani SA, Jang S. Pathophysiology and Management of Variceal Bleeding. Drugs 2021;81:647-67. [PMID: 33710585 DOI: 10.1007/s40265-021-01493-2] [Reference Citation Analysis]
128 Reynaert H, Geerts A. Pharmacological rationale for the use of somatostatin and analogues in portal hypertension. Aliment Pharmacol Ther. 2003;18:375-386. [PMID: 12940922 DOI: 10.1046/j.1365-2036.2003.01657.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 2.3] [Reference Citation Analysis]
129 Fujita T, Narumiya S. Roles of hepatic stellate cells in liver inflammation: a new perspective. Inflamm Regen. 2016;36:1. [PMID: 29259674 DOI: 10.1186/s41232-016-0005-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 5.2] [Reference Citation Analysis]
130 Xia JR, Liu NF, Zhu NX. Specific siRNA targeting the receptor for advanced glycation end products inhibits experimental hepatic fibrosis in rats. Int J Mol Sci. 2008;9:638-661. [PMID: 19325776 DOI: 10.3390/ijms9040638] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
131 Luisa S, Vitale G, Sorbo AR, Maurizio P, Lodovico RG. Hepatic vein transit time of second-generation ultrasound contrast agent: new tool in the assessment of portal hypertension. J Ultrasound 2017;20:43-52. [PMID: 28298943 DOI: 10.1007/s40477-016-0226-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
132 Iizuka M, Murata T, Hori M, Ozaki H. Increased contractility of hepatic stellate cells in cirrhosis is mediated by enhanced Ca2+-dependent and Ca2+-sensitization pathways. Am J Physiol Gastrointest Liver Physiol. 2011;300:G1010-G1021. [PMID: 21393429 DOI: 10.1152/ajpgi.00350.2010] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
133 Anavi S, Madar Z, Tirosh O. Non-alcoholic fatty liver disease, to struggle with the strangle: Oxygen availability in fatty livers. Redox Biol. 2017;13:386-392. [PMID: 28667907 DOI: 10.1016/j.redox.2017.06.008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
134 Ji H, Meng Y, Zhang X, Luo W, Wu P, Xiao B, Zhang Z, Li X. Aldosterone induction of hepatic stellate cell contraction through activation of RhoA/ROCK-2 signaling pathway. Regul Pept. 2011;169:13-20. [PMID: 21545816 DOI: 10.1016/j.regpep.2011.04.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
135 Winau F, Hegasy G, Weiskirchen R, Weber S, Cassan C, Sieling PA, Modlin RL, Liblau RS, Gressner AM, Kaufmann SH. Ito Cells Are Liver-Resident Antigen-Presenting Cells for Activating T Cell Responses. Immunity 2007;26:117-29. [DOI: 10.1016/j.immuni.2006.11.011] [Cited by in Crossref: 278] [Cited by in F6Publishing: 258] [Article Influence: 19.9] [Reference Citation Analysis]
136 Oben JA, Yang S, Lin H, Ono M, Diehl AM. Norepinephrine and neuropeptide Y promote proliferation and collagen gene expression of hepatic myofibroblastic stellate cells. Biochem Biophys Res Commun 2003;302:685-90. [PMID: 12646223 DOI: 10.1016/s0006-291x(03)00232-8] [Cited by in Crossref: 57] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
137 Ando W, Yokomori H, Kaneko F, Kaneko M, Igarashi K, Suzuki H. Serum Autotaxin Concentrations Reflect Changes in Liver Stiffness and Fibrosis After Antiviral Therapy in Patients with Chronic Hepatitis C. Hepatol Commun. 2018;2:1111-1122. [PMID: 30202824 DOI: 10.1002/hep4.1230] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
138 周雯, 杨玲, 胡胜军. Rho蛋白与肝星状细胞. 世界华人消化杂志 2009; 17(24): 2469-2473 [DOI: 10.11569/wcjd.v17.i24.2469] [Reference Citation Analysis]
139 Boyer-Diaz Z, Domingo JC, De Gregorio E, Manicardi N, Aristu-Zabalza P, Cordobilla B, Abad-Jordà L, Ortega-Ribera M, Fernández-Iglesias A, Marí M, Bosch J, Gracia-Sancho J. A Nutraceutical Rich in Docosahexaenoic Acid Improves Portal Hypertension in a Preclinical Model of Advanced Chronic Liver Disease. Nutrients 2019;11:E2358. [PMID: 31623374 DOI: 10.3390/nu11102358] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
140 Liu Y, Li Y, Yang W, Cao G. H2 S inhibits the activation of hepatic stellate cells and downregulates the expression of urotensin II. Hepatol Res. 2013;43:670-678. [PMID: 23131022 DOI: 10.1111/hepr.12002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
141 Friedman SL. Hepatic fibrosis-overview. Toxicology. 2008;254:120-129. [PMID: 18662740 DOI: 10.1016/j.tox.2008.06.013] [Cited by in Crossref: 240] [Cited by in F6Publishing: 226] [Article Influence: 18.5] [Reference Citation Analysis]
142 Guturu P, Shah V. New insights into the pathobiology of portal hypertension. Hepatol Res 2009;39:1016-9. [PMID: 19796039 DOI: 10.1111/j.1872-034X.2009.00553.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
143 Viñas O, Bataller R, Sancho-bru P, Ginès P, Berenguer C, Enrich C, Nicolás JM, Ercilla G, Gallart T, Vives J, Arroyo V, Rodés J. Human hepatic stellate cells show features of antigen-presenting cells and stimulate lymphocyte proliferation. Hepatology 2003;38:919-29. [DOI: 10.1002/hep.1840380418] [Cited by in Crossref: 145] [Cited by in F6Publishing: 73] [Article Influence: 8.1] [Reference Citation Analysis]
144 Jalan R, De Chiara F, Balasubramaniyan V, Andreola F, Khetan V, Malago M, Pinzani M, Mookerjee RP, Rombouts K. Ammonia produces pathological changes in human hepatic stellate cells and is a target for therapy of portal hypertension. J Hepatol. 2016;64:823-833. [PMID: 26654994 DOI: 10.1016/j.jhep.2015.11.019] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 7.7] [Reference Citation Analysis]
145 Oben JA, Yang S, Lin H, Ono M, Diehl AM. Acetylcholine promotes the proliferation and collagen gene expression of myofibroblastic hepatic stellate cells. Biochemical and Biophysical Research Communications 2003;300:172-7. [DOI: 10.1016/s0006-291x(02)02773-0] [Cited by in Crossref: 38] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
146 Nguyen-Lefebvre AT, Selzner N, Wrana JL, Bhat M. The hippo pathway: A master regulator of liver metabolism, regeneration, and disease. FASEB J 2021;35:e21570. [PMID: 33831275 DOI: 10.1096/fj.202002284RR] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
147 Chen XL, Chen TW, Li ZL, Zhang XM, Chen N, Zeng NL, Li H, Tang HJ, Pu Y, Li CP. Spleen size measured on enhanced MRI for quantitatively staging liver fibrosis in minipigs. J Magn Reson Imaging. 2013;38:540-547. [PMID: 23349034 DOI: 10.1002/jmri.24007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
148 Furneaux R. Liver haemodynamics as they relate to portosystemic shunts in the dog: A review. Research in Veterinary Science 2011;91:175-80. [DOI: 10.1016/j.rvsc.2010.11.017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
149 Jiang Y, Que W, Zhu P, Li XK. The Role of Diverse Liver Cells in Liver Transplantation Tolerance. Front Immunol 2020;11:1203. [PMID: 32595648 DOI: 10.3389/fimmu.2020.01203] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
150 Geerts A. On the origin of stellate cells: mesodermal, endodermal or neuro-ectodermal. J Hepatol. 2004;40:331-334. [PMID: 14739107 DOI: 10.1016/j.jhep.2003.12.006] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 3.3] [Reference Citation Analysis]
151 Lin HC, Huang YT, Yang YY, Lee PC, Hwang LH, Lee WP, Kuo YJ, Lee KC, Hsieh YC, Liu RS. Beneficial effects of dual vascular endothelial growth factor receptor/fibroblast growth factor receptor inhibitor brivanib alaninate in cirrhotic portal hypertensive rats. J Gastroenterol Hepatol. 2014;29:1073-1082. [PMID: 24325631 DOI: 10.1111/jgh.12480] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
152 Mikuriya Y, Tashiro H, Kuroda S, Nambu J, Kobayashi T, Amano H, Tanaka Y, Ohdan H. Fatty liver creates a pro-metastatic microenvironment for hepatocellular carcinoma through activation of hepatic stellate cells. Int J Cancer. 2015;136:E3-E13. [PMID: 25053237 DOI: 10.1002/ijc.29096] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
153 de Vries RJ, Pendexter CA, Cronin SEJ, Marques B, Hafiz EOA, Muzikansky A, van Gulik TM, Markmann JF, Stott SL, Yeh H, Toner M, Uygun K, Tessier SN. Cell release during perfusion reflects cold ischemic injury in rat livers. Sci Rep 2020;10:1102. [PMID: 31980677 DOI: 10.1038/s41598-020-57589-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
154 Hennenberg M, Trebicka J, Kohistani Z, Stark C, Nischalke H, Krämer B, Körner C, Klein S, Granzow M, Fischer H, Heller J, Sauerbruch T. Hepatic and HSC-specific sorafenib effects in rats with established secondary biliary cirrhosis. Lab Invest 2011;91:241-51. [DOI: 10.1038/labinvest.2010.148] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 4.1] [Reference Citation Analysis]
155 Mulaikal TA, Emond JC. Physiology and Anatomy of the Liver. In: Wagener G, editor. Liver Anesthesiology and Critical Care Medicine. Cham: Springer International Publishing; 2018. pp. 3-19. [DOI: 10.1007/978-3-319-64298-7_1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
156 Kennedy-Lydon T, Crawford C, Wildman SS, Peppiatt-Wildman CM. Nonsteroidal anti-inflammatory drugs alter vasa recta diameter via pericytes. Am J Physiol Renal Physiol 2015;309:F648-57. [PMID: 26202223 DOI: 10.1152/ajprenal.00199.2015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
157 Freise C, Heldwein S, Erben U, Hoyer J, Köhler R, Jöhrens K, Patsenker E, Ruehl M, Seehofer D, Stickel F, Somasundaram R. K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells. Liver Int 2015;35:1244-52. [PMID: 25212242 DOI: 10.1111/liv.12681] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
158 Molodykh OP, Lushnikova EL, Klinnikova MG, Nepomnyashchikh LM. Structural reorganization of the rat liver under cytotoxic effect of doxorubicin. Bull Exp Biol Med 2006;141:639-44. [DOI: 10.1007/s10517-006-0241-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
159 Bloom S, Kemp W, Lubel J. Portal hypertension: pathophysiology, diagnosis and management: Portal hypertension current concepts. Intern Med J 2015;45:16-26. [DOI: 10.1111/imj.12590] [Cited by in Crossref: 41] [Cited by in F6Publishing: 24] [Article Influence: 6.8] [Reference Citation Analysis]
160 Rahman N, Kuramochi M, Izawa T, Kuwamura M, Yamate J. Characterization of Immature Myofibroblasts of Stellate Cell or Mesenchymal Cell Origin in D-Galactosamine-Induced Liver Injury in Rats. Vet Pathol 2021;58:80-90. [PMID: 33054583 DOI: 10.1177/0300985820963097] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
161 Fiorucci S, Antonelli E, Tocchetti P, Morelli A. Treatment of portal hypertension with NCX-1000, a liver-specific NO donor. A review of its current status. Cardiovasc Drug Rev. 2004;22:135-146. [PMID: 15179450 DOI: 10.1111/j.1527-3466.2004.tb00136.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
162 Yang L, Han B, Zhang M, Wang YH, Tao K, Zhu MX, He K, Zhang ZG, Hou S. Activation of BK Channels Prevents Hepatic Stellate Cell Activation and Liver Fibrosis Through the Suppression of TGFβ1/SMAD3 and JAK/STAT3 Profibrotic Signaling Pathways. Front Pharmacol 2020;11:165. [PMID: 32210801 DOI: 10.3389/fphar.2020.00165] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
163 Reynaert H, Sermon F, Urbain D, Geerts A. Stellate cells in the digestive tract. Curr Gastroenterol Rep 2003;5:177-9. [DOI: 10.1007/s11894-003-0015-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
164 Lin H, Yang Y, Hou M, Huang Y, Lee F, Lee S. Acute Administration of Carvedilol is More Effective than Propranolol Plus Isosorbide-5-Mononitrate in the Reduction of Portal Pressure in Patients with Viral Cirrhosis. Am J Gastroenterology 2004;99:1953-8. [DOI: 10.1111/j.1572-0241.2004.40179.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
165 Tripathi D, Hayes PC. The role of carvedilol in the management of portal hypertension. Eur J Gastroenterol Hepatol. 2010;22:905-911. [PMID: 20093937 DOI: 10.1097/meg.0b013e3283367a99] [Cited by in Crossref: 26] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
166 Van Rossen E, Liu Z, Blijweert D, Eysackers N, Mannaerts I, Schroyen B, El Taghdouini A, Edwards B, Davies KE, Sokal E, Najimi M, Reynaert H, van Grunsven LA. Syncoilin is an intermediate filament protein in activated hepatic stellate cells. Histochem Cell Biol 2014;141:85-99. [PMID: 24043511 DOI: 10.1007/s00418-013-1142-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
167 Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology. 2008;134:1655-1669. [PMID: 18471545 DOI: 10.1053/j.gastro.2008.03.003] [Cited by in Crossref: 1758] [Cited by in F6Publishing: 1744] [Article Influence: 135.2] [Reference Citation Analysis]
168 Zhang F, Wang F, He J, Lian N, Wang Z, Shao J, Ding H, Tan S, Chen A, Zhang Z, Wang S, Zheng S. Regulation of hepatic stellate cell contraction and cirrhotic portal hypertension by Wnt/β-catenin signalling via interaction with Gli1. Br J Pharmacol 2021;178:2246-65. [PMID: 33085791 DOI: 10.1111/bph.15289] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
169 Blomley MJ, Lim AK, Harvey CJ, Patel N, Eckersley RJ, Basilico R, Heckemann R, Urbank A, Cosgrove DO, Taylor-Robinson SD. Liver microbubble transit time compared with histology and Child-Pugh score in diffuse liver disease: a cross sectional study. Gut. 2003;52:1188-1193. [PMID: 12865280 DOI: 10.1136/gut.52.8.1188] [Cited by in Crossref: 96] [Cited by in F6Publishing: 83] [Article Influence: 5.3] [Reference Citation Analysis]
170 Cárdenas A, Ginès P. Mechanisms of Sodium Retention, Ascites Formation, and Renal Dysfunction in Cirrhosis. In: Sanyal AJ, Shah VH, editors. Portal Hypertension. Totowa: Humana Press; 2005. pp. 65-84. [DOI: 10.1007/978-1-59259-885-4_5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
171 Mulaikal TA, Emond JC. Physiology and Anatomy of the Liver. In: Wagener G, editor. Liver Anesthesiology and Critical Care Medicine. New York: Springer; 2012. pp. 3-20. [DOI: 10.1007/978-1-4614-5167-9_1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
172 Steib CJ, Gmelin L, Bilzer M, Göke B, Gerbes AL. Portal Pressure Regulation following Kupffer Cell Activation: Control of Prostaglandin Production by Heme Oxygenases. Digestion 2013;87:102-9. [DOI: 10.1159/000345145] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
173 Kim MY, Baik SK. [Pathophysiology of portal hypertension, what's new?]. Korean J Gastroenterol 2010;56:129-34. [PMID: 20847603 DOI: 10.4166/kjg.2010.56.3.129] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
174 Schmidt HHHW, Schmidt PM, Stasch J. NO- and Haem-Independent Soluble Guanylate Cyclase Activators. In: Schmidt HHHW, Hofmann F, Stasch J, editors. cGMP: Generators, Effectors and Therapeutic Implications. Berlin: Springer Berlin Heidelberg; 2009. pp. 309-39. [DOI: 10.1007/978-3-540-68964-5_14] [Cited by in Crossref: 96] [Cited by in F6Publishing: 91] [Reference Citation Analysis]
175 Shafik AN, Khodeir MM, Gouda NA, Mahmoud ME. Improved antifibrotic effect of a combination of verapamil and silymarin in rat-induced liver fibrosis. Arab J Gastroenterol 2011;12:143-9. [PMID: 22055593 DOI: 10.1016/j.ajg.2011.07.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
176 Yi SH, Zhang Y, Tang D, Zhu L. Mechanical force and tensile strain activated hepatic stellate cells and inhibited retinol metabolism. Biotechnol Lett 2015;37:1141-52. [PMID: 25773194 DOI: 10.1007/s10529-015-1785-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
177 Meijer EM, van Dijk CGM, Kramann R, Verhaar MC, Cheng C. Implementation of Pericytes in Vascular Regeneration Strategies. Tissue Eng Part B Rev 2021. [PMID: 33231500 DOI: 10.1089/ten.TEB.2020.0229] [Reference Citation Analysis]
178 Nollevaux M, Guiot Y, Horsmans Y, Leclercq I, Rahier J, Geubel A, Sempoux C. Hypervitaminosis A-induced liver fibrosis: stellate cell activation and daily dose consumption. Liver Int 2006;26:182-6. [DOI: 10.1111/j.1478-3231.2005.01207.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 2.7] [Reference Citation Analysis]
179 Koilan S, Hamilton D, Baburyan N, Padala MK, Weber KT, Guntaka RV. Prevention of liver fibrosis by triple helix-forming oligodeoxyribonucleotides targeted to the promoter region of type I collagen gene. Oligonucleotides. 2010;20:231-237. [PMID: 20818932 DOI: 10.1089/oli.2010.0244] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
180 de Mesquita FC, Guixé-Muntet S, Fernández-Iglesias A, Maeso-Díaz R, Vila S, Hide D, Ortega-Ribera M, Rosa JL, García-Pagán JC, Bosch J, de Oliveira JR, Gracia-Sancho J. Liraglutide improves liver microvascular dysfunction in cirrhosis: Evidence from translational studies. Sci Rep 2017;7:3255. [PMID: 28607430 DOI: 10.1038/s41598-017-02866-y] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 7.5] [Reference Citation Analysis]
181 Sauvant P, Cansell M, Atgié C. Vitamin A and lipid metabolism: relationship between hepatic stellate cells (HSCs) and adipocytes. J Physiol Biochem. 2011;67:487-496. [PMID: 21626400 DOI: 10.1007/s13105-011-0101-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
182 Luo W, Meng Y, Ji HL, Pan CQ, Huang S, Yu CH, Xiao LM, Cui K, Ni SY, Zhang ZS. Spironolactone lowers portal hypertension by inhibiting liver fibrosis, ROCK-2 activity and activating NO/PKG pathway in the bile-duct-ligated rat. PLoS One. 2012;7:e34230. [PMID: 22479572 DOI: 10.1371/journal.pone.0034230] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
183 Fiorucci S, Antonelli E, Morelli A. Nitric oxide and portal hypertension: a nitric oxide-releasing derivative of ursodeoxycholic acid that selectively releases nitric oxide in the liver. Dig Liver Dis. 2003;35 Suppl 2:S61-S69. [PMID: 12846445 DOI: 10.1016/s1590-8658(03)00053-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
184 van der Hoven B, Gommers D, Bakker J. Critical Illness and the Hepatic Microcirculation: A Review. Intensive Care Medicine. Berlin: Springer Berlin Heidelberg; 2007. pp. 643-50. [DOI: 10.1007/978-3-540-49433-1_57] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]